Core Viewpoint - The company, Steady Medical (300888), has experienced a significant decline in market value despite having strong performance metrics compared to its peers in the medical dressing industry [1] Group 1: Company Performance - Steady Medical is recognized for having the best performance and the strongest growth rate among its peers, with earnings per share equaling the combined total of its competitors, ZhenDe and Aomei [1] - The company has been focusing on enhancing operational performance and shareholder value, leading to increased product and brand recognition in the market [1] Group 2: Market Conditions - The company's stock price is influenced by multiple factors, including macroeconomic conditions, industry policies, and market sentiment [1] - Despite the challenges in market valuation, the company maintains a positive outlook on its future prospects due to strengthened core competitiveness [1]

Core Insights - The personal care products sector experienced a rise of 0.83% on November 19, with HaoYue Care leading the gains [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Sector Performance - The personal care products sector saw significant individual stock movements, with notable gainers including: - JiaNi Care (605009) at 34.85, up 6.41% with a trading volume of 90,600 shares and a turnover of 311 million yuan - YiYi Co. (001206) at 34.01, up 6.12% with a trading volume of 113,200 shares and a turnover of 380 million yuan - Reliable Co. (301009) at 14.94, up 4.48% with a trading volume of 167,800 shares and a turnover of 247 million yuan [1] Capital Flow - The personal care products sector saw a net inflow of 45.14 million yuan from institutional investors, while retail investors experienced a net outflow of 115 million yuan [2][3] - Notable capital flows included: - Yanjiang Co. (300658) with a net outflow of 57.28 million yuan from retail investors, despite a net inflow of 41.57 million yuan from institutional investors [3] - BeiJiaJie (603059) with a net inflow of 24.08 million yuan from institutional investors, but a net outflow of 23.27 million yuan from retail investors [3]

Summary of the Conference Call for稳健医疗 Company Overview - **Company**: 稳健医疗 (Steady Medical) - **Industry**: Medical Supplies and Health Consumer Products Key Points and Arguments 1. **Financial Performance**: In the first three quarters of 2025, the company reported a revenue increase of 30% year-on-year and a net profit increase of 32%, indicating a recovery growth phase post-pandemic driven by the synergy between the medical and consumer segments [2][3][31] 2. **Medical Segment Growth**: The high-end dressing business saw a revenue growth of 30% in 2024 with a gross margin exceeding 50%. The surgical consumables business, after consolidating GRI, experienced a growth rate close to 200%, becoming a key driver for the medical segment [2][3][31] 3. **Consumer Products Segment**: The health consumer products segment focuses on four core categories: wet and dry cotton towels, sanitary napkins, adult clothing, and children's clothing. The sanitary napkin business grew over 60%, making it the fastest-growing category in the consumer segment [2][3][31] 4. **Brand Strategy**: The company achieved significant success in the cotton towel and sanitary napkin markets through a "hit product" strategy, with products like ultra-soft cotton towels and medical-grade sanitary napkins seeing growth rates exceeding 300% and doubling, respectively [2][20][21] 5. **E-commerce Expansion**: The company is actively expanding its online channels, particularly in live-streaming e-commerce, which, although currently below the industry average, has significant growth potential and is expected to become a key driver for future performance [2][3][31] 6. **Mergers and Acquisitions**: Through acquisitions like GRI, the company has supplemented key categories and driven rapid growth in related businesses, enhancing its positioning as a one-stop procurement solution for consumables [2][15][31] 7. **Future Growth Projections**: The medical business is expected to maintain a growth rate of around 13% over the next two years, while the consumer products segment is projected to grow between 13% and 18%, indicating high-quality growth potential [3][31] 8. **Market Position**: In the low-value medical consumables industry, the company holds a competitive edge with a gross margin of 36.52%, higher than competitors like 澳美 and 正德 [10][31] 9. **International Market Strategy**: The company is enhancing its own brand development in international markets and expanding through cross-border e-commerce, focusing on both B2B and B2C channels [13][31] 10. **Product Structure**: The company’s main product categories include traditional wound care products, high-end dressings, surgical room consumables, disease control protection products, and health care products, with significant revenue contributions from each [14][31] Additional Important Insights 1. **Management and Ownership**: The actual controller, Mr. Li Jianxian, and his family hold nearly 70% of the shares, with a management team comprising experienced executives from both the medical and fast-moving consumer goods sectors [8][31] 2. **Market Dynamics**: The sanitary napkin market is experiencing significant changes, with traditional leading brands losing market share, providing opportunities for emerging brands like 奈斯公主 [28][29][30] 3. **Consumer Trends**: The company is focusing on enhancing brand image and values through various marketing strategies, including social media and live-streaming, to attract younger consumers [21][30] 4. **Challenges in Baby Clothing Segment**: The growth of the children's clothing segment is expected to be limited due to declining birth rates, with only single-digit growth projected for 2025 [19][23][31] This comprehensive summary captures the essential aspects of the conference call, highlighting the company's performance, strategic initiatives, and market positioning within the medical and consumer products sectors.

Investment Strategy Overview - The report emphasizes the stabilization of global tariff negotiations, which does not alter the core competitiveness of global manufacturing, and highlights optimism towards two major industrial chains and a price increase cycle [3][4]. Industry Performance Review - As of November 14, 2025, the SW textile and apparel index has increased by 16.9%, ranking 17th in relative performance across the market. The manufacturing sector shows higher certainty compared to brands still in recovery [4][8]. - Domestic demand is at a low point in 2025 but is expected to recover in 2026-2027, focusing on the characteristics of young consumer groups to explore high-growth areas in new consumption [4][21]. New Consumption Trends - High-performance outdoor apparel is identified as a growth area with low penetration and high potential, with the market size projected to reach 102.7 billion yuan in 2024, growing by 17% year-on-year [4][33]. - Discount retail is highlighted as a scarce high-growth area within the consumption sector, with rapid expansion in urban outlets and hard discount specialty stores [4][46]. - The personal care and cleaning market, particularly wet wipes, is noted for its rapid growth and increasing necessity among young consumers, with a market size in China expected to reach 100 billion yuan [4][62]. - The sleep economy is emerging as a significant market, with explosive growth in household textile products, driven by young consumers' acceptance [4][20]. - The report discusses Nike's innovation cycle, which is expected to benefit from inventory replenishment and product innovation, similar to Adidas's recovery cycle [4][20]. - The Australian wool price increase cycle is anticipated due to supply contraction and demand highlights, with potential market space comparable to previous high points in 2011 and 2018 [4][20]. - The healthcare material upgrade cycle presents broad replacement opportunities for overseas non-woven fabrics [4][20]. Global Manufacturing Insights - The report notes that the resolution of tariff variables is expected to lead to a new growth phase for leading companies [4][27]. - The textile industry has undergone a pressure test for external demand, with recent tariff negotiations expected to boost export chain expectations for 2026 [4][26]. Investment Recommendations - The report suggests focusing on high-growth new consumption areas and the competitive strength of global manufacturing as key investment strategies [4][27].

截至2025年11月17日收盘，稳健医疗(300888)报收于41.67元，下跌0.93%，换手率0.75%，成交量4.35万 手，成交额1.82亿元。 当日关注点 交易信息汇总资金流向 11月17日主力资金净流出2290.08万元；游资资金净流出311.97万元；散户资金净流入2602.05万元。 公司公告汇总关于完成工商变更登记的公告 稳健医疗用品股份有限公司于2025年8月20日召开第四届董事会第七次会议，于2025年9月24日召开2025 年第一次临时股东会，审议通过修订《公司章程》并办理工商变更登记的议案。同日召开职工代表大 会，选举张燕女士为公司第四届董事会职工代表董事。公司已取得深圳市市场监督管理局出具的《登记 通知书》，完成工商变更登记及公司章程备案手续。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自【交易信息汇总】：11月17日主力资金净流出2290.08万元，散户资金净流入2602.05万元。 来自【公司公告汇总】：稳健医疗已完成修订《公司章程》及职工代表董事选举的工商变更登 记。 ...

证券日报网讯 11月17日晚间，稳健医疗发布公告称，公司于近日取得了深圳市市场监督管理局出具的 《登记通知书》，公司工商变更登记及公司章程备案等手续已完成。 （文章来源：证券日报） ...

证券之星消息，截至2025年11月17日收盘，稳健医疗(300888)报收于41.67元，下跌0.93%，换手率 0.75%，成交量4.35万手，成交额1.82亿元。 11月17日的资金流向数据方面，主力资金净流出2290.08万元，占总成交额12.6%，游资资金净流出 311.97万元，占总成交额1.72%，散户资金净流入2602.05万元，占总成交额14.32%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-17 | 41.67 -0.93% | | -2290.08万 | -12.60% | -311.97万 | -1.72% | 2602.05万 | - 14.32% | | 2025-11-14 | 42.06 | -2.25% | -959.83万 | -3.55% | -748.94万 | -2.77% | 1708.76万 | 6.31% | | 2025-1 ...

证券代码：300888 证券简称：稳健医疗 公告编号：2025-040 公司于近日取得了深圳市市场监督管理局出具的《登记通知书》，公司工商 变更登记及公司章程备案等手续已完成。 特此公告。 稳健医疗用品股份有限公司董事会 二〇二五年十一月十七日 关于完成工商变更登记的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏。 稳健医疗用品股份有限公司（以下简称"公司"）分别于 2025 年 8 月 20 日、2025 年 9 月 24 日召开第四届董事会第七次会议、2025 年第一次临时股东会， 审议通过《关于修订<公司章程>并办理工商变更登记的议案》。公司根据《公司 法》《上市公司章程指引》等法律法规、规范性文件的规定，结合公司实际情况， 对《公司章程》进行了修订。公司于 2025 年 9 月 24 日召开职工代表大会，经与 会职工代表审议，同意选举张燕女士为公司第四届董事会职工代表董事，任期自 职工代表大会审议通过之日起至第四届董事会任期届满之日止。具体内容详见公 司披露在巨潮资讯网（www.cninfo.com.cn）的相关公告。 稳健医疗用品股份有限公司 ...

Core Insights - The personal care products sector experienced a decline of 0.71% on November 17, with Baiya Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3972.03, down 0.46%, while the Shenzhen Component Index closed at 13202.0, down 0.11% [1] Stock Performance - Yanjing Co., Ltd. saw a significant increase of 10.42%, closing at 10.60 with a trading volume of 403,600 shares and a transaction value of 416 million yuan [1] - Other notable performers included Yiyi Co., Ltd. with a 1.13% increase and Kela Co., Ltd. with a 0.98% increase [1] - Baiya Co., Ltd. led the decline with a drop of 2.70%, closing at 21.66 with a trading volume of 63,000 shares and a transaction value of 137 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 67.19 million yuan from institutional investors, while retail investors contributed a net inflow of 26.53 million yuan [2] - The capital flow data indicates that Yanjing Co., Ltd. had a net inflow of 32.94 million yuan from institutional investors, while Baiya Co., Ltd. experienced a net outflow of 5.45 million yuan [3]

Group 1: Core Insights - The North American personal care market is experiencing intensified competition, with Procter & Gamble showing better profitability compared to revenue, while Kimberly-Clark is seeing efficiency improvements from its transformation efforts [1][2] - In the domestic market, upstream supply chain companies such as Yanjian, Jieya, and Nuobang have reported significant revenue growth of 17%, 107%, and 23% respectively, indicating a recovery in overseas orders [1][3] Group 2: Company Performance - Procter & Gamble reported global revenue of $22.39 billion and net profit of $4.75 billion for FY26Q1, reflecting a year-on-year increase of 3% and 20% respectively, with challenges in the North American market [2] - Kimberly-Clark's Q3 revenue reached $4.15 billion, with a net profit of $450 million, showing a slight revenue increase but a significant decline in net profit due to transformation costs [2] Group 3: Market Trends - The domestic personal care market is facing fierce competition, leading to increased sales expenses and weaker profit growth compared to revenue for many companies [3] - The upgrade of global disposable hygiene materials is accelerating, with a shift from internal competition to external expansion, particularly in the non-woven fabric supply chain [4] Group 4: Investment Recommendations - Companies with established global supply chain layouts, such as Yanjian, are recommended for investment due to the ongoing upgrade trend in overseas hygiene products [4] - Jieya is expected to benefit from increased orders in its wet wipes business, while Sturdy Medical is noted for its stable profitability amid diverse business growth [4]